Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
The Real Rate Index45.30.00Palanor: Inflation Pulse50.7+0.09Palanor: Geopolitical Stress60.0-2.16Palanor: Liquidity57.9-0.79Palanor: Capital Tightness47.5+0.91Palanor: Industrial Pulse70.10.00Palanor: AI Margin Compression53.4+0.29Palanor: Consumer Confidence48.6+0.50Palanor: US Dollar Strength46.50.00Palanor: Labor Heat63.2-0.01Palanor: Recession Vocabulary28.1+0.54Palanor: Uncertainty Index53.4+1.24Palanor: US Jobs Health40.30.00Palanor: Energy Transition37.0-0.52Palanor: Reshoring Sentiment22.8+0.54Palanor: AI Substitution28.4-0.24The Social Fabric Index45.70.00Palanor: Geopolitical Anxiety19.4-0.45Palanor: Quit Pressure37.6+0.42The Mania Index88.00.00The Palanor Index57.1-0.51Cost Disease Spread33.20.00Palanor: US vs China49.5-0.17Rise of Socialism Index40.8-0.26The Bubble Memory79.90.00Palanor: Steward Confidence50.8+0.13The Long Watch90.30.00The Reshoring Index55.2+0.00The Capital Return Index81.0-0.75The Discourse Index72.4+1.83The Hesitation Index30.8-6.58Palanor AI Inference Cost Index71.2-0.03The AI Capex Race Index78.4+1.36The Boardroom Index82.5-0.00The Layoff Cycle Index32.8-2.51Capital Deployment Posture Index62.3+1.26The Consumer Health Index41.7-2.96Labor Hours Composite44.40.00The Dollar Erosion Index66.6+0.14Palanor: Risk Appetite36.2+0.83
PalanorPalanor

Company Dossier · Health Care

Tempus AI

TEMNasdaqWILMINGTON, US-DE, USLarge cap
  • Russell 1000

What Tempus AI is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.

Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →

The latest read

Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.

  • Revenue over the four quarters to June 30, 2026: $1.43 billion, up 51% from a year earlier.SEC EDGAR filings (XBRL)
  • Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: −$0.26 billion.SEC EDGAR filings (XBRL)
  • Capital expenditure over the four quarters to June 30, 2026: $0.03 billion, up 50% from a year earlier.SEC EDGAR filings (XBRL)
  • Long-term debt issued in the fiscal year to December 31, 2025: $0.20 billion.SEC EDGAR filings (10-K)
  • Latest earnings call or results release (July 30, 2026): sentiment 0.80 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.90 of 1.Palanor Discourse
  • Guidance in the last 90 days: 1 outlook figure raised, 0 lowered, 1 held.Guidance Ledger (8-K results releases)
  • Latest annual report (filed February 24, 2026): 5 risk factors added, 3 removed.Risk Factor Changes (10-K Item 1A)
  • Insiders were net sellers in Q3 2026: $87.0 million on the open market.SEC Form 4
  • 488 institutional managers reported a position at June 30, 2026 (+61 on the quarter before).SEC Form 13F
  • H-1B filings certified in Q2 2026: 26 (24 a year earlier).U.S. Department of Labor (OFLC)

Company Posture

How Company Posture is measured →

Company Posture covers S&P 500 companies.

Credit

How these are built →

No bond term sheets or tagged debt on file for Tempus AI yet.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Cash flow

Business

Tempus AI: free cash flow, trailing twelve months

Operating cash flow minus capital expenditure, $ billions, from SEC filings

−$0.26BData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Tempus AI: operating cash flow and capital expenditure

Trailing twelve months, $ billions, from SEC filings

Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Tempus AI: revenue, trailing twelve months

$ billions, from SEC filings

$1.4BData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Capital returned and raised

Business

Tempus AI: share buybacks by fiscal year

Cash paid to repurchase common stock, $ billions, from the 10-K

$0.00BData to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Tempus AI: debt issued and repaid by fiscal year

Long-term debt, $ billions, from the 10-K

Data to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Tempus AI: interest coverage

Operating income ÷ interest expense, trailing twelve months, from SEC filings

−5.1Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

What the company says

Business

Tempus AI: guidance raised minus lowered

Guidance Ledger statements by quarter

1.0Data 23 days ago
ImageDataGuidance Ledger by Palanor · source: SEC EDGAR
Business

Tempus AI: earnings call sentiment

Palanor Discourse score per call, −1 to +1

0.80Data to Jul 2026
ImageDataPalanor calculation
Business

Tempus AI: earnings call confidence

Palanor Discourse score per call, 0 to 1

0.90Data to Jul 2026
ImageDataPalanor calculation
Business

Tempus AI: risk factors added per annual report

New Item 1A risk factors in each 10-K

5.0Data to Feb 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Hiring and ownership

Business

Tempus AI: H-1B filings certified

Labor Condition Applications by quarter received

26.0Data to Jun 2026
ImageDataU.S. Department of Labor, Office of Foreign Labor Certification disclosure data, dol.gov
Business

Tempus AI: insider net buying

Open-market purchases minus sales by officers and directors, $ millions, by quarter

−$87.1MData 23 days ago
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Tempus AI: institutional holders

Managers reporting a position on Form 13F, by quarter

488.0Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

  1. Oct 20, 2026Lobbying
    Lobbying report (VALCOUR LLC)third_quarter 2026 · $0.1 million
  2. Oct 15, 2026Lobbying
    Lobbying report (CAPITOL COUNSEL LLC)third_quarter 2026 · $0.1 million
  3. Sep 8, 2026Patent
    Patent granted: DETECTING LOW EJECTION FRACTION FROM ELECTROCARDIOGRAM DATA USING ARTIFICIAL INTELLIGENCEUS 12727863
  4. Sep 1, 2026Patent
    Patent granted: SYSTEMS, METHODS, AND ARTICLES FOR IMPUTING DIRECTED TEMPORAL MEASUREMENTSUS 12725682
  5. Aug 31, 2026Trademark
    Trademark application: BUILT FOR THE REAL WORLD
  6. Aug 18, 2026Patent
    Patent granted: TRANSLATING AI ALGORITHMS FROM 12-LEAD CLINICAL ECGS TO PORTABLE AND CONSUMER ECGS WITH FEWER LEADSUS 12708310
  7. Jul 28, 2026Patent
    Patent granted: TECHNIQUES FOR RESOLVING DISCORDANT HER2 STATUS IN PATHOLOGY IMAGES FOR DIAGNOSING BREAST CANCERUS 12694302
  8. Jul 21, 2026Patent
    Patent granted: METHODS OF NORMALIZING AND CORRECTING RNA EXPRESSION DATAUS 12688906
  9. Jul 20, 20268-K
    Material agreement signedItem 1.01
  10. Jul 20, 2026Lobbying
    Lobbying report (VALCOUR LLC)second_quarter 2026 · $0.1 million
  11. Jul 16, 2026Lobbying
    Lobbying report (CAPITOL COUNSEL LLC)second_quarter 2026 · $0.1 million
  12. Jun 30, 2026Private credit
    Loans held by business development companies (Tempus AI, Inc.)$1.9 million at cost
  13. Jun 2, 2026Trademark
    Trademark application: TEMPUS ECG-TR
  14. Jun 2, 2026Trademark
    Trademark application: TEMPUS ECG-HF
  15. May 22, 20268-K
    Shareholder vote resultsItem 5.07
  16. May 13, 20268-K
    Material agreement signedItem 1.01
  17. May 13, 20268-K
    Material agreement terminatedItem 1.02
  18. Apr 20, 2026Lobbying
    Lobbying report (VALCOUR LLC)first_quarter 2026 · $0.1 million
  19. Apr 16, 2026Lobbying
    Lobbying report (CAPITOL COUNSEL LLC)first_quarter 2026 · $0.1 million
  20. Apr 15, 2026Trademark
    Trademark application: TEMPUS ECG-AF
  21. Apr 15, 2026Trademark
    Trademark application: TEMPUS ECG-LOW EF
  22. Feb 24, 202610-K
    Annual report (10-K)5 risk factors added, 3 removed
  23. Jan 20, 2026Lobbying
    Lobbying report (VALCOUR LLC)fourth_quarter 2025 · $0.1 million
  24. Jan 18, 2026Lobbying
    Lobbying report (CAPITOL COUNSEL LLC)fourth_quarter 2025 · $0.1 million
  25. Jul 3, 20258-K
    Material agreement signedItem 1.01
  26. May 23, 20258-K
    Shareholder vote resultsItem 5.07
  27. Feb 25, 2025S-1
    Registration statement (S-1)
  28. Feb 24, 202510-K
    Annual report (10-K)
  29. Feb 3, 20258-K
    Material agreement signedItem 1.01
  30. Nov 5, 20248-K
    Material agreement signedItem 1.01

Peers

Companies in the same sector in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

CompanyRevenueFree cash flowThrough
LivaNova LIVN$1.5B$0.1BJun 30, 2026
Penumbra, Inc. PEN$1.5B$0.2BJun 30, 2026
HealthEquity HQY$1.4B$0.5BJul 31, 2026
Haemonetics HAE$1.4B$0.3BJun 27, 2026
Lantheus Holdings LNTH$1.6B—Jun 30, 2026
Madrigal Pharmaceuticals MDGL$1.3B−$0.2BJun 30, 2026
Halozyme HALO$1.7B$0.8BJun 30, 2026
Sotera Health SHC$1.2B$0.1BJun 30, 2026

Identity

SEC CIK
1717115
LEI
2549009LA0KWRAGQBX50
Wikidata
Q127040202

Built from SEC EDGAR filings (public domain), the Guidance and KPI Ledgers, Palanor Discourse, U.S. Department of Labor filings, USPTO, USAspending and Senate lobbying records, and rights-checked news headlines. Updated nightly; this page was built Oct 22, 2026. How the Dossier is built

S&P 500, S&P 100, S&P MidCap 400 and Dow Jones Industrial Average are trademarks of S&P Dow Jones Indices LLC or its affiliates; Nasdaq-100 is a trademark of Nasdaq, Inc.; Russell 1000 is a trademark of FTSE Russell. Membership is shown for identification only. Palanor is not affiliated with or endorsed by the index owners.

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.